Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Zavegepant, sold under the brand name Zavzpret, is a medication used for the treatment of migraine. Zavegepant is a calcitonin gene-related peptide receptor antagonist. It is sprayed into the nose. It is sold by Pfizer.
Applications, Medical uses & Overview
Explore the main themes, entities and connections around Zavegepant. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment sold nasal medical name zavzpret calcitonin gene-related peptide receptor antagonist migraine number medication pfizer acute brand used sprayed nose
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Zavegepant | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Zavegepant | ATC code | N02CD08 (WHO) | 1.00 | infobox |
| Zavegepant | CAS Number | 1337918-83-8 | 1.00 | infobox |
| Zavegepant | CAS Number | as HCl: 1414976-20-7 | 1.00 | infobox |
| Zavegepant | ChEBI | CHEBI:229643 | 1.00 | infobox |
| Zavegepant | ChEMBL | ChEMBL2397415 | 1.00 | infobox |
| Zavegepant | ChEMBL | as HCl: ChEMBL4650220 | 1.00 | infobox |
| Zavegepant | ChemSpider | 30814207 | 1.00 | infobox |
| Zavegepant | CompTox Dashboard (EPA) | DTXSID101352039 | 1.00 | infobox |
| Zavegepant | Drug class | Calcitonin gene-related peptide receptor antagonist | 1.00 | infobox |
| Zavegepant | DrugBank | DB15688 | 1.00 | infobox |
| Zavegepant | Formula | C36H46N8O3 | 1.00 | infobox |
| Zavegepant | KEGG | D11898 | 1.00 | infobox |
| Zavegepant | KEGG | as HCl: D11899 | 1.00 | infobox |
| Zavegepant | Legal status | US: ℞-only | 1.00 | infobox |
| Zavegepant | License data | US DailyMed: Zavegepant | 1.00 | infobox |
| Zavegepant | Molar mass | 638.817 g·mol−1 | 1.00 | infobox |
| Zavegepant | Other names | BHV-3500 | 1.00 | infobox |
| Zavegepant | PubChem CID | 53472683 | 1.00 | infobox |
| Zavegepant | PubChem CID | as HCl: 134819878 | 1.00 | infobox |
| Zavegepant | Routes of administration | Nasal | 1.00 | infobox |
| Zavegepant | Trade names | Zavzpret | 1.00 | infobox |
| Zavegepant | UNII | ODU3ZAZ94J | 1.00 | infobox |
| Zavegepant | UNII | as HCl: 000QCM6HAL | 1.00 | infobox |
| Zavegepant | is a | calcitonin gene-related peptide receptor antagonist | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.